Skip to content

AtriCure

US · ATRC #2543 by market cap Listed 1970
55.39 +1.28 +2.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Company notice
    Atreca | 8-K: Atreca Reports Fourth Quarter and Full-Year 2021 Financial Results and ATRC-101 Data Update
    SEC · 2022/3/4
  • Rating change
    Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/7/24
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Prime Medicine, Inc. (PRME) and Community Health (CYH)
    TipRanks · 2026/7/24
  • Rating change
    UBS Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2026/7/28
  • Rating change
    Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/7/24
  • Rating change
    Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/24
  • Company notice
    Atreca | 8-K: Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
    SEC · 2023/3/30
  • Rating change
    Oppenheimer Maintains AtriCure(ATRC.US) With Hold Rating
    Market Newswire · 2026/7/24
  • Rating change
    BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/24
  • Rating change
    BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/8/24
  • Rating change
    Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/9/17
  • Rating change
    Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/8/27
  • BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $63
    Market Newswire · 2026/10/12
  • Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/11/12
  • Rating change
    Freedom Capital Markets Downgrades AtriCure(ATRC.US) to Hold Rating, Raises Target Price to $57
    Market Newswire · 2026/10/2
  • Citizens JMP Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $68
    Market Newswire · 2026/10/21
  • A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $62 to $70
    Market Newswire · 2026/11/5
  • Rating change
    CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/8/12
  • Earnings Flash (ATRC) AtriCure, Inc. Posts Q3 Adjusted EPS $0.17 per Share, Vs. FactSet Est of $-0.06
    MT Newswires · 2026/11/4
  • Rating change
    Needham Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $64
    Market Newswire · 2026/9/2
  • Rating change
    Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/7/13
  • Rating change
    BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Cuts Target Price to $45
    Market Newswire · 2026/5/6
  • Rating change
    CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/5/6
  • Rating change
    BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $54
    Market Newswire · 2026/2/18
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Atricure (ATRC) and Tempus AI, Inc. Class A (TEM)
    TipRanks · 2026/5/6

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

AtriCure discussion 0 comments

Add a comment